Docteur MCN - Hématologie financials
A multi-period view of the public annual-account figures reported for Docteur MCN - Hématologie, with comparable measures and links to available source documents.
Company overviewRegistry number
0698701787
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for Docteur MCN - Hématologie
2025 versus 2024
- Operating line
- €123,824
- EBITDA
- €122,680
- Total assets
- €301,253
- Equity
- €121,717
-5.7%
+2.8%
+17.6%
-26.4%
EBITDA margin +99.1% · Equity ratio +40.4%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.